PD-1 inhibitors in endometrial cancer

被引：13

作者：

Barroso-Sousa, Romualdo

Ott, Patrick A. ^{[1
,2
]}

机构：

[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

[2] Harvard Med Sch, Boston, MA 02115 USA

来源：

ONCOTARGET | 2017年 / 8卷 / 63期

关键词：

endometrial cancer; immunotherapy; PD-1; inhibition; microsatellite instability-high; POLE; IMMUNOTHERAPY; PEMBROLIZUMAB; BLOCKADE;

D O I：

10.18632/oncotarget.22583

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：106169 / 106170

页数：2

共 7 条

[1] Integrated genomic characterization of endometrial carcinoma
Getz, Gad
Gabriel, Stacey B.
Cibulskis, Kristian
Lander, Eric
Sivachenko, Andrey
Sougnez, Carrie
Lawrence, Mike
Kandoth, Cyriac
Dooling, David
Fulton, Robert
Fulton, Lucinda
Kalicki-Veizer, Joelle
McLellan, Michael D.
O'Laughlin, Michelle
Schmidt, Heather
Wilson, Richard K.
Ye, Kai
Ding, Li
Mardis, Elaine R.
Ally, Adrian
Balasundaram, Miruna
Birol, Inanc
Butterfield, Yaron S. N.
Carlsen, Rebecca
Carter, Candace
Chu, Andy
Chuah, Eric
Chun, Hye-Jung E.
Dhalla, Noreen
Guin, Ranabir
Hirst, Carrie
Holt, Robert A.
Jones, Steven J. M.
Lee, Darlene
Li, Haiyan I.
Marra, Marco A.
Mayo, Michael
Moore, Richard A.
Mungall, Andrew J.
Plettner, Patrick
Schein, Jacqueline E.
Sipahimalani, Payal
Tam, Angela
Varhol, Richard J.
Robertson, A. Gordon
Pashtan, Itai
Saksena, Gordon
Onofrio, Robert C.
Schumacher, Steven E.
Tabak, Barbara
[J]. NATURE, 2013, 497 (7447) : 67 - 73
[2] Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade Immunotherapy
Johanns, Tanner M.
Miller, Christopher A.
Dorward, Ian G.
Tsien, Christina
Chang, Edward
Perry, Arie
Uppaluri, Ravindra
Ferguson, Cole
Schmidt, Robert E.
Dahiya, Sonika
Ansstas, George
Mardis, Elaine R.
Dunn, Gavin P.
[J]. CANCER DISCOVERY, 2016, 6 (11) : 1230 - 1236
[3] Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer
Mehnert, Janice M.
Panda, Anshuman
Zhong, Hua
Hirshfield, Kim
Damare, Sherri
Lane, Katherine
Sokol, Levi
Stein, Mark N.
Rodriguez-Rodriquez, Lorna
Kaufman, Howard L.
Ali, Siraj
Ross, Jeffrey S.
Pavlick, Dean C.
Bhanot, Gyan
White, Eileen P.
DiPaola, Robert S.
Lovell, Ann
Cheng, Jonathan
Ganesan, Shridar
[J]. JOURNAL OF CLINICAL INVESTIGATION, 2016, 126 (06) : 2334 - 2340
[4] Hypermutated tumours in the era of immunotherapy: The paradigm of personalised medicine
Nebot-Bral, Laetitia
Brandao, David
Verlingue, Loic
Rouleau, Etienne
Caron, Olivier
Despras, Emmanuelle
El-Dakdouki, Yolla
Champiat, Stephane
Aoufouchi, Said
Leary, Alexandra
Marabelle, Aurelien
Malka, David
Chaput, Nathalie
Kannouche, Patricia L.
[J]. EUROPEAN JOURNAL OF CANCER, 2017, 84 : 290 - 303
[5] Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1-Positive Endometrial Cancer: Results From the KEYNOTE-028 Study
Ott, Patrick A.
Bang, Yung-Jue
Berton-Rigaud, Dominique
Elez, Elena
Pishvaian, Michael J.
Rugo, Hope S.
Puzanov, Igor
Mehnert, Janice M.
Aung, Kyaw L.
Lopez, Juanita
Carrigan, Marion
Saraf, Sanatan
Chen, Mei
Soria, Jean-Charles
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (22) : 2535 - +
[6] Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Rizvi, Naiyer A.
Hellmann, Matthew D.
Snyder, Alexandra
Kvistborg, Pia
Makarov, Vladimir
Havel, Jonathan J.
Lee, William
Yuan, Jianda
Wong, Phillip
Ho, Teresa S.
Miller, Martin L.
Rekhtman, Natasha
Moreira, Andre L.
Ibrahim, Fawzia
Bruggeman, Cameron
Gasmi, Billel
Zappasodi, Roberta
Maeda, Yuka
Sander, Chris
Garon, Edward B.
Merghoub, Taha
Wolchok, Jedd D.
Schumacher, Ton N.
Chan, Timothy A.
[J]. SCIENCE, 2015, 348 (6230) : 124 - 128
[7] Neoantigens in cancer immunotherapy
Schumacher, Ton N.
Schreiber, Robert D.
[J]. SCIENCE, 2015, 348 (6230) : 69 - 74

← 1 →